依达拉奉治疗急性脑梗塞的疗效观察

目的探讨依达拉奉注射液治疗急性脑梗塞的有效性和安全性,方法对104例急性脑梗塞患者随机分为治疗组和对照组．治疗组在常规治疗的基础上加用依达拉奉注射液静滴。两组实行同样康复和护理模式,治疗前后观察两组临订疗效。结果治疗前两组Barthel指数和ESS评分差异无显著性（P〉0．05）,治疗1个月后治疗组Barthel指数和ESS评分明显高于对照组（P〈0．01）。结论依达拉奉治疗急生脑梗塞有确切实效。     

依达拉奉治疗急性脑梗死临床疗效评价

目的观察依达拉奉治疗急性脑梗死的疗效。方法急性脑梗死120例随机分为治疗组(依达拉奉加常规治疗),对照组(常规治疗)两组,治疗组60例,对照组60例。观察治疗后神经功能改善情况并进行疗效评定。结果治疗组治疗后各时期ESS及ADL评分均显著高于对照组(<0.05),14d、21d及30d的ESS及ADL评分显著高于对照组(<0.05)。结论依达拉奉能显著提高急性脑梗死的疗效。     

依达拉奉联合奥扎格雷钠治疗急性脑梗死的疗效观察

目的观察依达拉奉联合奥扎格雷钠治疗急性脑梗死的疗效。方法将88例急性脑梗死患者随机分为治疗组44例,采用依达拉奉与奥扎格雷钠联合治疗;对照组44例使用奥扎格雷钠治疗。比较两组治疗效果。结果治疗级显交往率63.6%,总有效率95.5%,显著高于对照组的显效率40.9%,总有效率75.0%,P<0.05,其差异具有统计学意义。结论依达拉奉联合奥扎格雷钠治疗急性脑梗死效果好且安全。     

长春西汀辅助治疗抑郁症疗效观察

目的观察长春西汀辅助治疗抑郁症患者的疗效。方法将68例抑郁症患者随机分为实验组和对照组,分别使用盐酸氟西汀（百忧解）并长春西汀联合治疗和单独使用盐酸氟西汀治疗8周,采用汉密尔顿抑郁量表（HAMD）、Zung氏抑郁自评量表（SDS）评价疗效。结果实验组和对照组皆疗效显著（P均〈0．01）,且实验组对躯体化、睡眠障碍因子的改善较对照组更明显,有显著性统计学差异（P均〈0．05）。结论长春西汀对抑郁症有辅助治疗作用。     

依达拉奉联合马来酸桂哌齐特治疗急性脑梗死的疗效观察

目的：观察依达拉奉联合马来酸桂哌齐特治疗急性脑梗死(ACI)的临床疗效和安全性。方法采用随机对照试验,将发病72h内的ACI患者随机分为两组。治疗组(28例)应用依达拉奉30mg静脉滴注,2次/d;马来酸桂哌齐特320mg静脉滴注,1次/d,两药均使用14d。对照组(25例)应用丹红40ml代替依达拉奉及马来酸桂哌齐特,基础治疗两组相同。治疗前后进行神经功能缺损(ESS)评分。结果14d后治疗组神经功能缺损评分明显低于对照组,治疗总有效率明显高于对照组(<0.05),且无明显不良反应。结论依达拉奉联合马来酸桂哌齐特治疗急性脑梗死疗效确切,安全可靠。     

依达拉奉联用高氧液治疗急性脑梗死疗效观察

目的 观察依达拉奉联用高氧液治疗急性脑梗死的疗效并进行分析和评价。方法 对30例脑梗死患者在常规治疗的基础上加用依达拉奉和高氧液治疗，并与对照组40例比较。结果 应用依达拉奉与高氧液治疗组临床疗效较对照组有显著提高。结论 依达拉奉联用高氧液治疗急性脑梗死能明显提高显效率及改善神经功能。     

长春西汀药理作用与临床应用观察

目的：总结长春西汀的药理作用和观察其应用治疗急性脑梗死的临床疗效、安全性。方法选取我院内科住院的80例患者,随机分为观察组和对照组各40例,观察组在常规治疗基础上应用长春西汀注射液,对照组在常规治疗基础上应用丹参注射液,观察两组用药后神经功能缺损程度、临床症状和体征有无改善,进行临床疗效评定。结果观察组有效率95%,对照组有效率82.5%,观察组明显高于对照组(<0.05),具有统计学意义,两组均未见明显的不良反应。结论长春西汀能有效改善急性脑梗死患者的神经功能,具有良好的临床疗效且较为安全。     

奥扎格雷联合依达拉奉治疗急性脑梗死的效果

目的 观察奥扎格雷联合依达拉奉治疗急性脑梗死的效果。方法 选择2018年5月~2019年5月在我院诊治的急性脑梗死患者106例,采用随机数字表法分为对照组和观察组,各53例。对照组采用奥扎格雷治疗,观察组在对照组基础上联合依达拉奉治疗,比较两组临床治疗总有效率、治疗前后神经功能缺损评分（NIHSS）和日常生活能力评分（Barthel）、临床不良反应。结果 观察组治疗总有效率为94.33%,高于对照组的81.13%,差异有统计学意义（P＜0.05）;治疗后两组NIHSS评分均低于治疗前,且观察组低于对照组,差异有统计学意义（P＜0.05）;治疗后两组Barthel评分均高于治疗前,且观察组高于对照组,差异有统计学意义（P＜0.05）;观察组临床不良反应率为5.66%,与对照组的7.54%比较,差异无统计学意义（P＞0.05）。结论 奥扎格雷联合依达拉奉治疗急性脑梗死效果确切,有助于改善神经功能,提高患者日常生活能力,同时临床不良反应小,联合用药方案安全可行,值得临床应用。     

依达拉奉治疗急性脑梗死临床疗效及安全性分析

随着我国人口老龄化和生活方式的改变，脑梗死发病率、致残率、死亡率不断增加，严重影响人类健康和生活质量。急性脑梗死目前主要的治疗手段是溶栓和神经保护治疗。依达拉奉是一种新型羟自由基清除剂，对神经细胞起到保护作用，减轻脑缺血引起的水肿及组织损伤，从而改善预后。我院自2005年6月～2007年6月应用依达拉奉治疗急性脑梗死，取得较好疗效，现报告如下。     

Effect of vinpocetine on retrograde axoplasmic transport

Vinpocetine, a derivate of vincamine, is widely used in the clinical pharmacotherapy of cerebral circulatory diseases. Herewith we report on a novel effect of vinpocetine: inhibition of retrograde axoplasmic transport of nerve growth factor (NGF) in the peripheral nerve. Blockade of retrograde transport of NGF results in transganglionic degenerative atrophy (TDA) in the segmentally related ipsilateral superficial spinal dorsal horn, which is characterized by depletion of the marker enzymes fluoride-resistant acid phosphatase (FRAP) and thiamine monophosphatase (TMP). At the same time, pain-related neuropeptides such as substance P (SP) and calcitonin gene-related peptide (CGRP), are depleted from lamina I-III from the segmentally related, ipsitateral Rolando substance of the spinal cord. On the basis of these experiments it is suggested that vinpocetine may result in a locally restricted decrease of nociception, that might be useful in clinical treatment of intractable pain. Pilot self-experiments support this assumption.     

磁共振联合磁敏感加权成像评估急性脑梗死的临床价值

目的:探讨磁共振成像（MRI）联合磁敏感加权成像（SWI）评估急性脑梗死预后的临床价值。方法:采用随机数字表法将100例急性脑梗死患者分为观察组（n=50）和对照组（n=50）。对照组行MRI检查,观察组行MRI联合SWI检查。比较两组患者的疾病检出率、脑微出血检出情况。结果:观察组疾病检出率显著高于对照组（96.0% vs 78.0%, P<0.05）;观察组脑微出血检出率显著高于对照组（64.0% vs 12.0%, P<0.05）;观察组的出血检出面积为（972.83±110.54） mm2,显著高于对照组的（532.71±110.53） mm2（P<0.05）。观察组脑梗死面积诊断评分显著小于对照组（P<0.05）。入院15 d后,观察组神经功能缺损程度评分明显低于对照组（P<0.05）;观察组神经功能缺损程度稳定率及好转率显著高于对照组（P<0.05）。结论:MRI联合SWI检查对急性脑梗死疾病的检出率明显较高,能够准确预测脑微出血,有助于制定正确的临床治疗方案,改善急性脑梗死患者的预后。     

星状神经节阻滞对急性心肌梗死患者应激激素水平的影响

目的 观察星状神经节阻滞对急性心肌梗死患者体内去甲肾上腺素（NE）、肾上腺素（adrenalin，ADR）、促肾上腺皮质激素（ACTH）、皮质醇（cortisol，ODR）等应激激素水平的影响。方法 选择已被确诊为急性心肌梗死患者68例，随机分为治疗组（34例）和对照组（34例）．治疗组患者采用星状神经节阻滞治疗，两周为一疗程；对照组常规内科治疗。于阻滞前及阻滞后24、48、72、144h抽取静脉血标本。测定各时段的NE、肾上腺素、ACTH、皮质醇应激激素的含量。结果 阻滞后治疗组患者的NE、ADR、ACTH、ODR应激激素的含量与阻滞前及同时段的对照组比较有明显的降低，P〈0．05。结论 星状神经节阻滞可快速有效地缓解由于冠状动脉供血不足引起的缺血性疼痛，抑制应激反应，降低患者体内NE、ADR、ACTH、00R应激激素的水平。     

Effect of intravenous magnesium on ventricular tachyarrhythmias associated with acute myocardial infarction.

Ventricular ectopy and left ventricular dysfunction are important predictive factors for an unfavourable outcome following an acute myocardial infarction (MI). Tachyarrhythmias are a major cause of death subsequent to MI. Magnesium was postulated to have an antiarrhythmic effect after MI. Therefore we have investigated the influence of intravenous and oral magnesium (Mg) therapy on ventricular tachyarrhythmias. 67 patients with myocardial infarction (MI) diagnosed according to the WHO criteria of anamnesis, infarct-specific electrocardiogram (ECG), and enzymatic status were included in a prospective study. 23 patients (group 1) received 2 g Mg per day (= 82 mmol Mg/24 h) intravenously for the first 3 days followed by oral magnesium adipate administration of 3 x 2 coated tablets of magnesium 50 Apogepha (= 300 mg Mg/24 h or 12.34 mmol Mg/24 h, respectively) for the full duration of the study. 26 patients (group 2) received only i.v. magnesium for the first 3 days after admission (2 g Mg/24 h). The results of this treatment were compared to those of a control group of 18 MI patients without magnesium administration. All groups were identical with regard to other forms of treatment. The magnesium levels in serum and erythrocytes of all patients were measured at the following time points: days 0 (admission time), 1, 2, the day of discharge (about day 20) and after 12 weeks. The tachyarrhythmias were monitored by 24-h-continuous-electrocardiography on days 0, 1 and on the day before discharge (about day 20). The serum magnesium levels rose significantly during i.v. Mg-administration (1 and 2 day) but decreased in group 2 subsequently until the time of discharge from hospital. In contrast group 1 patients receiving oral as well as intravenous magnesium did not show this drop. The uptake of magnesium into the erythrocytes was less obvious. The erythrocyte magnesium concentration of the control group remained significantly low in serum and red blood cells. Significantly less ventricular premature beats and runs (< 5 ventricular premature beats and > 5 ventricular premature beats) compared to admission day were observed in both treated groups. These data suggest that the frequency of ventricular tachyarrhythmias is reduced by administration of intravenous magnesium and support an early high dose administration of intravenous magnesium in the wake of myocardial infarction.     

氟伐他汀与丁苯酞软胶囊联合治疗对急性脑梗死患者的影响

目的 探讨急性脑梗死病人进行丁苯酞软胶囊与氟伐他汀联合治疗的临床效果及对患者血清C反应蛋白的动态影响.方法 选取我院2013年6月-2014年5月急性脑梗死病人100例,根据随机数字表法分为研究组、对照组,每组50例,两组均进行血压控制、抗感染、脱水、营养脑细胞、降低颅压等常规疗法,研究组在此基础上进行丁苯酞软胶囊与氟伐他汀疗法,对照组仅服用氟伐他汀,两组均治疗2W,比较两组的临床效果;比较两组治疗前后的神经功能缺损程度评分量表(NIHSS)评分、Barthel指数评分、FMA评分情况;比较两组治疗前后的纤维蛋白原、红细胞压积等血液流变指标;比较两组治疗前、治疗后3d、治疗后1W、治疗后2W的血清C反应蛋白(CRP)水平的动态改变.结果 研究组的临床有效率为84.0％,对照组的临床有效率为52.0％,两组比较差异有统计学意义(P＜0.05);治疗后,研究组神经功能缺损程度量表(NIHSS)评分情况显著优于对照组(P＜0.05);研究组治疗后的Bar-thel指数评分、FMA评分情况显著优于对照组(P＜0.05);治疗后研究组的纤维蛋白原、红细胞压积等血液流变指标显著优于对照组,差异有统计学意义(P＜0.05);研究组治疗后3d、治疗后1W、治疗后2W的血清CRP水平优于对照组,差异有统计学意义(P＜0.05).结论 对急性脑梗死病人进行丁苯酞软胶囊与氟伐他汀联合疗法,可显著改善病人的神经功能缺损程度,提高其日常生活能力,改善其血流动力学指标及血清C反应蛋白,临床效果确切,值得临床推广.     

罗格列酮对兔急性心肌梗死后心室重构及心功能的影响

目的 探讨罗格列酮(Ros)对兔急性心肌梗死(AMI)后心室重构和心功能的影响.方法 将30只日本大耳白兔随机分为:假手术(Sham)组,AMI模型组,Ros组,每组10只.永久性结扎冠状动脉左前降支中上1/3处制作AMI模型,术后6h Ros组给予Ros 3mg/(kg·d)灌胃,AMI组及sham龃给予等量蒸馏水灌...     

Effect of acute body positional changes on the haemodynamics of rats with and without myocardial infarction

In humans, the lateral recumbent position has a beneficial effect on haemodynamics. If this effect is substantial in small animals too, there is a risk of misinterpretation in preclinical investigations. Therefore, the aim of this study was to analyse the impact of acute changes in body position on haemodynamics in rats. Healthy rats (n=21) and rats post myocardial infarction (n=20) were randomly positioned supine, prone, or on the right or left side. In each position, we measured haemodynamic parameters by pressure-tip catheter and thermodilution. We found that left ventricular contractility (dP/dtmax) was significantly elevated in both lateral positions as compared to the supine position in healthy rats. In healthy rats and following infarction, cardiac index (CI) and stroke volume index (SVI) were significantly higher in both lateral positions as compared to the supine or prone position. Of importance, if SVI values in the supine position in healthy rats (0.095 +/- 0.003 ml (100 g)(-1)) are compared to SVI values measured in different positions after myocardial infarction, the SVI can be either significantly lower in the supine (0.084 +/- 0.003 ml (100 g)(-1)) or significantly higher in the left lateral position (0.105 +/- 0.003 ml (100 g)(-1)). We conclude that post myocardial infarction and in healthy control rats, important haemodynamic values are increased in lateral positions as compared to prone or supine positions. Analysing haemodynamic data in rats may therefore result in misinterpretation if the body position is inconsistent.     

Solitaire AB支架机械介入取栓术联合溶栓治疗急性脑梗死的临床研究

目的探讨Solitaire AB支架机械介入取栓术联合溶栓治疗急性脑梗死的临床效果。方法选取我院2016年3月至2019年2月收治的80例急性脑梗死患者,将其中40例行单纯溶栓治疗的患者作为溶栓组,40例行Solitaire AB支架机械介入取栓术联合溶栓治疗的患者作为联合组。观察2组患者的治疗效果,采用美国国立卫生研究院卒中量表(NIHSS)评价患者治疗前后不同时间点的神经功能情况,采用Rankin量表(mRS)评价患者的肢体功能及预后状况,比较2组患者不良反应发生率。结果联合组患者的治疗总有效率高于溶栓组,差异具有统计学意义(P<0.05);所有患者治疗后1 d、1周、1个月、3个月的NIHSS评分均较治疗前降低,且联合组低于溶栓组,差异具有统计学意义(P<0.05);联合组患者治疗后的mRS评分低于溶栓组,差异具有统计学意义(P<0.05);联合组患者的不良反应发生率低于溶栓组,差异具有统计学意义(P<0.05)。结论对急性脑梗死患者应用Solitaire AB支架机械介入取栓术联合溶栓治疗可提高治疗效果,改善患者的神经功能,提高预后效果,减少不良反应的发生。     

多奈哌齐联合奥拉西坦治疗急性脑梗死后血管性痴呆的临床疗效

目的 探讨多奈哌齐联合奥拉西坦治疗急性脑梗死后血管性痴呆的临床疗效.方法 60例急性脑梗死后血管性痴呆患者被随机分为对照组和联合给药组,每组30例.对照组患者每日口服奥拉西坦3次(0.8g/次),联合给药组在对照组基础上每日口服多奈哌齐1次(5 mg/次),共治疗4周.在治疗前后,采用简明精神状态量表(MMSE)对患者...